NCT02244463 2024-01-12A Phase I/II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer and Incurably Poorly Differentiated or Radioidodine Refractory Differentiated Thyroid CancerDana-Farber Cancer InstitutePhase 1/2 Completed46 enrolled 18 charts